Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Mucopolysaccharidosis IV MeSH Descriptor Data 2025
Genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme.
Entry Version
MPS IV
Entry Term(s)
Eccentro-Osteochondrodysplasia
Eccentroosteochondrodysplasia
GALNS Deficiency
Galactosamine-6-Sulfatase Deficiency
MPS IV A
MPS IV B
MPS IVA
MPS IVB
Morquio A Disease
Morquio B Syndrome
Morquio Disease
Morquio Syndrome
Morquio Syndrome A
Morquio Syndrome B
Morquio Syndrome, Type B
Morquio's Disease
Morquio's Disease Type B
Morquio's Syndrome
Morquio-B Disease
Mucopolysaccharidosis 4
Mucopolysaccharidosis 4B
Mucopolysaccharidosis Type IV
Mucopolysaccharidosis Type IV A
Mucopolysaccharidosis Type IV B
Mucopolysaccharidosis Type IVA
Mucopolysaccharidosis Type IVB
Public MeSH Note
1992; see MUCOPOLYSACCHARIDOSIS 4 1980-1991, see ECCENTROOSTEOCHONDRODYSPLASIA 1963-1979; MORQUIO'S DISEASE was MORQUIO DISEASE see MUCOPOLYSACCHARIDOSIS 4 1980-1991
History Note
1992; use MUCOPOLYSACCHARIDOSIS 4 1980-1991, use ECCENTROOSTEOCHONDRODYSPLASIA 1963-1979; for MORQUIO'S DISEASE use MUCOPOLYSACCHARIDOSIS 4 1980-1991
Genetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme.